Buntanetap
Buntanetap ((+) -Phenserine) is an orally bioavailable small molecule inhibitor targeting toxic proteins implicated in neurodegeneration. It is utilized in preclinical research for Alzheimer's and Parkinson's disease, with studies demonstrating its effects in reducing amyloid-β and tau pathology in both cellular and animal models.
Product Specifications
CAS Number
116839-68-0
Product Name Alternative
BetaAmyloid, Beta Amyloid, cholinesterase, ANV S401, ANVS401, Amyloid-β, b Amyloid, bAmyloid, AChE., AChE, (+) Phenserine, (+) Phenserine, (+) -Phenserine, Huntingtin, Phenserine, β Amyloid, α-synuclein, βAmyloid
Field of Research
Neuroscience
Purity
98.20% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (14.82 mM) ; DMSO:200 mg/mL (592.73 mM)
Smiles
C[C@@]12C=3C (N (C) [C@@]1 (N (C) CC2) [H]) =CC=C (OC (NC4=CC=CC=C4) =O) C3
Molecular Formula
C20H23N3O2
Molecular Weight
337.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-10832M-PerCP 100 µL
S100B Monoclonal Antibody, PerCP Conjugated
Sign In for Pricing
View Details 
